ELITE PHARMACEUTICALS INC /NV/ reports

Company location: Northvale, NJ
Fiscal year end: 31 March

ELITE PHARMACEUTICALS INC /NV/ has filed 1,215 SEC EDGAR filings since 30 Jan 1998

Filter by type:
10-K
10-Q
8-K
SC13D
SC13G

SEC filing history

Showing 601-625 of 753 matching filings.

Per page

25

Current page

25

4

PRIMARY DOCUMENT

Filing date: 26 Apr 2012
Reporting date: 18 Apr 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 26 Apr 2012
Reporting date: 18 Apr 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 26 Apr 2012
Reporting date: 18 Apr 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 23 Apr 2012
Reporting date: 19 Apr 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 27 Mar 2012
Reporting date: 23 Mar 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 27 Mar 2012
Reporting date: 23 Mar 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 27 Mar 2012
Reporting date: 23 Mar 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 27 Mar 2012
Reporting date: 23 Mar 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 27 Mar 2012
Reporting date: 23 Mar 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 27 Mar 2012
Reporting date: 23 Mar 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

8-K File 001-15697

FORM 8-K

Filing date: 22 Mar 2012
Reporting date: 16 Mar 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 21 Mar 2012
Reporting date: 20 Mar 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 21 Mar 2012
Reporting date: 20 Mar 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 21 Mar 2012
Reporting date: 20 Mar 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 21 Mar 2012
Reporting date: 20 Mar 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 21 Mar 2012
Reporting date: 20 Mar 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 21 Mar 2012
Reporting date: 20 Mar 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 21 Mar 2012
Reporting date: 20 Mar 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 21 Mar 2012
Reporting date: 20 Mar 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 20 Mar 2012
Reporting date: 14 Mar 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 20 Mar 2012
Reporting date: 14 Mar 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 20 Mar 2012
Reporting date: 14 Mar 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 20 Mar 2012
Reporting date: 14 Mar 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4

PRIMARY DOCUMENT

Filing date: 20 Mar 2012
Reporting date: 14 Mar 2012
SEC evidence: Open document Open filing
Next action: Verify source filing

4/A

PRIMARY DOCUMENT

Filing date: 20 Mar 2012
Reporting date: 18 Jan 2011
SEC evidence: Open document Open filing
Next action: Verify source filing

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. to update or revoke optional consent for future visits. For more information, see our Privacy Policy .